+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Fondaparinux Market Size, Share & Trends Analysis Report By Type (Deep Vein Thrombosis), By Product (Branded, Generic), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • March 2025
  • Region: Global
  • Grand View Research
  • ID: 6062602
Description Jump to:
The global fondaparinux market size is estimated to reach USD 990.9 million by 2030, registering to grow at a CAGR of 6.3% from 2025 to 2030 . Fondaparinux is majorly used during knee and hip replacement surgeries. Arixtra, manufactured by GSK group of companies is the branded drug of Fondaparinux. The drug witnessed patent expiry in 2002. As the active molecule is highly complex to manufacture, it faced low generic competition until 2011. Generic manufacturer companies, such as Alchemia Ltd. and Apotex, Inc., received the Abbreviated New Drug Application approval in 2011 and instantly started the production of generic drugs.

Fondaparinux is used as an anticoagulant and shows improved survival compared with low-molecular-weight heparin. It is used for the prevention of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) and is administered subcutaneously. Moreover, Fondaparinux lowers the risk of ischemic events

The increasing collaboration between the key players for acquiring the Intellectual Property Rights (IPRs) in order to manufacture the molecule through patented technology is expected to drive growth. For instance, in July 2016 Dr. Reddy’s Laboratories Ltd. entered into an agreement with Alchemia Ltd. to purchase the IPRs of fondaparinux sodium for USD 17.5 million. In September 2014, Mylan N.V. purchased branded and generic versions of fondaparinux sodium from Aspen Global, Inc. for USD 225 million. The deal gave Mylan N.V. access to one of the two generics indicated for the treatment of PE.

Fondaparinux Market Report Highlights

  • The generic segment accounted for the largest revenue share of 52.1% in 2024 and is expected to maintain its dominance during the forecast period.
  • The Deep Vein Thrombosis (DVT) segment accounted for a leading share of the market in 2024.
  • Hospital pharmacies emerged as the leading distribution channel for fondaparinux in 2024
  • North America fondaparinux market dominated the global market and accounted for the largest revenue share of 37.6% in 2024

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This Report Addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Product
1.2.3. Distribution Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Fondaparinux Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
Chapter 4. Fondaparinux Market: Type Business Analysis
4.1. Type Market Share, 2024 & 2030
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Deep Vein Thrombosis
4.4.1. Deep Vein Thrombosis Market, 2018 - 2030 (USD Million)
4.5. Pulmonary Embolism
4.5.1. Pulmonary Embolism Market, 2018 - 2030 (USD Million)
Chapter 5. Fondaparinux Market: Product Business Analysis
5.1. Product Market Share, 2024 & 2030
5.2. Product Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
5.4. Branded
5.4.1. Branded Market, 2018 - 2030 (USD Million)
5.5. Generic
5.5.1. Generic Market, 2018 - 2030 (USD Million)
Chapter 6. Fondaparinux Market: Distribution Channel Business Analysis
6.1. Distribution Channel Market Share, 2024 & 2030
6.2. Distribution Channel Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
6.4. Hospital Pharmacies
6.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
6.5. Retail Pharmacies
6.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
6.6. Online Pharmacies
6.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)
Chapter 7. Fondaparinux Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
7.4.1. North America Fondaparinux Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Regulatory Framework
7.4.2.3. Competitive Insights
7.4.2.4. U.S. Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Regulatory Framework
7.4.3.3. Competitive Insights
7.4.3.4. Canada Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Regulatory Framework
7.4.4.3. Competitive Insights
7.4.4.4. Mexico Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Europe
7.5.1. Europe Fondaparinux Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Regulatory Framework
7.5.2.3. Competitive Insights
7.5.2.4. UK Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Regulatory Framework
7.5.3.3. Competitive Insights
7.5.3.4. Germany Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Regulatory Framework
7.5.4.3. Competitive Insights
7.5.4.4. France Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Regulatory Framework
7.5.5.3. Competitive Insights
7.5.5.4. Italy Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Regulatory Framework
7.5.6.3. Competitive Insights
7.5.6.4. Spain Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Regulatory Framework
7.5.7.3. Competitive Insights
7.5.7.4. Denmark Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Regulatory Framework
7.5.8.3. Competitive Insights
7.5.8.4. Sweden Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Regulatory Framework
7.5.9.3. Competitive Insights
7.5.9.4. Norway Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Fondaparinux Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Regulatory Framework
7.6.2.3. Competitive Insights
7.6.2.4. Japan Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Regulatory Framework
7.6.3.3. Competitive Insights
7.6.3.4. China Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Regulatory Framework
7.6.4.3. Competitive Insights
7.6.4.4. India Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Australia
7.6.5.1. Key Country Dynamics
7.6.5.2. Regulatory Framework
7.6.5.3. Competitive Insights
7.6.5.4. Australia Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. Regulatory Framework
7.6.6.3. Competitive Insights
7.6.6.4. South Korea Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Regulatory Framework
7.6.7.3. Competitive Insights
7.6.7.4. Thailand Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Fondaparinux Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Regulatory Framework
7.7.2.3. Competitive Insights
7.7.2.4. Brazil Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Regulatory Framework
7.7.3.3. Competitive Insights
7.7.3.4. Argentina Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. MEA
7.8.1. MEA Fondaparinux Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Regulatory Framework
7.8.2.3. Competitive Insights
7.8.2.4. South Africa Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Regulatory Framework
7.8.3.3. Competitive Insights
7.8.3.4. Saudi Arabia Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Regulatory Framework
7.8.4.3. Competitive Insights
7.8.4.4. UAE Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Regulatory Framework
7.8.5.3. Competitive Insights
7.8.5.4. Kuwait Fondaparinux Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. Abbott Laboratories Inc.
8.5.1.1. Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Alchemia Limited
8.5.2.1. Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Apotex Inc.
8.5.3.1. Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. GSK plc
8.5.4.1. Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. Lupin Pharmaceuticals, Inc
8.5.5.1. Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. ScinoPharm Taiwan Ltd
8.5.6.1. Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. Dr. Reddy’s Laboratories Ltd.
8.5.7.1. Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives.
8.5.8. Bayer Healthcare AG
8.5.8.1. Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. GlaxoSmithKline
8.5.9.1. Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. Boehringer Ingelheim
8.5.10.1. Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
8.5.11. Sanofi
8.5.11.1. Overview
8.5.11.2. Financial Performance
8.5.11.3. Product Benchmarking
8.5.11.4. Strategic Initiatives
8.5.12. WisMed
8.5.12.1. Overview
8.5.12.2. Financial Performance
8.5.12.3. Product Benchmarking
8.5.12.4. Strategic Initiatives
8.5.13. Kaifeng
8.5.13.1. Overview
8.5.13.2. Financial Performance
8.5.13.3. Product Benchmarking
8.5.13.4. Strategic Initiatives
8.5.14. Mylan
8.5.14.1. Overview
8.5.14.2. Financial Performance
8.5.14.3. Product Benchmarking
8.5.14.4. Strategic Initiatives
List of Tables
Table 1 List Of Secondary Sources
Table 2 List Of Abbreviations
Table 3 Global Fondaparinux Market, By Region, 2018 - 2030 (USD Million)
Table 4 Global Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 5 Global Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 6 Global Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 7 North America Fondaparinux Market, By Country, 2018 - 2030 (USD Million)
Table 8 North America Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 9 North America Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 10 North America Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 11 U.S. Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 12 U.S. Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 13 U.S. Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 14 Canada Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 15 Canada Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 16 Canada Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 17 Mexico Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 18 Mexico Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 19 Mexico Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 20 Europe Fondaparinux Market, By Country, 2018 - 2030 (USD Million)
Table 21 Europe Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 22 Europe Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 23 Europe Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 24 UK Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 25 UK Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 26 UK Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 27 Germany Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 28 Germany Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 29 Germany Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 30 France Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 31 France Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 32 France Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 33 Italy Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 34 Italy Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 35 Italy Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 36 Spain Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 37 Spain Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 38 Spain Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 39 Denmark Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 40 Denmark Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 41 Denmark Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 42 Sweden Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 43 Sweden Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 44 Sweden Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 45 Norway Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 46 Norway Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 47 Norway Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Fondaparinux Market, By Country, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 51 Asia Pacific Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 52 Japan Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 53 Japan Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 54 Japan Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 55 China Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 56 China Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 57 China Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 58 India Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 59 India Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 60 India Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 61 Australia Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 62 Australia Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 63 Australia Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 64 South Korea Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 65 South Korea Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 66 South Korea Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 67 Thailand Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 68 Thailand Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 69 Thailand Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 70 Latin America Fondaparinux Market, By Country, 2018 - 2030 (USD Million)
Table 71 Latin America Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 72 Latin America Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 73 Latin America Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 74 Brazil Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 75 Brazil Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 76 Brazil Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 77 Argentina Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 78 Argentina Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 79 Argentina Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Fondaparinux Market, By Country, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 84 South Africa Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 85 South Africa Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 86 South Africa Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 90 UAE Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 91 UAE Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 92 UAE Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 93 Kuwait Fondaparinux Market, By Type, 2018 - 2030 (USD Million)
Table 94 Kuwait Fondaparinux Market, By Product, 2018 - 2030 (USD Million)
Table 95 Kuwait Fondaparinux Market, By Distribution Channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Fondaparinux Market Segmentation
Fig. 2 Market Research Process
Fig. 3 Data Triangulation Techniques
Fig. 4 Primary Research Pattern
Fig. 5 Market Research Approaches
Fig. 6 Value-Chain-Based Sizing & Forecasting
Fig. 7 Market Formulation & Validation
Fig. 8 Market Snapshot
Fig. 9 Type and Product Outlook (USD Million)
Fig. 10 Distribution Channel Outlook (USD Million)
Fig. 11 Competitive Landscape
Fig. 12 Fondaparinux Market Dynamics
Fig. 13 Fondaparinux Market: Porter’s Five Forces Analysis
Fig. 14 Fondaparinux Market: PESTLE Analysis
Fig. 15 Fondaparinux Market: Type Segment Dashboard
Fig. 16 Fondaparinux Market: Type Market Share Analysis, 2024 & 2030
Fig. 17 Deep Vein Thrombosis Market, 2018 - 2030 (USD Million)
Fig. 18 Pulmonary Embolism Market, 2018 - 2030 (USD Million)
Fig. 19 Fondaparinux Market: Product Segment Dashboard
Fig. 20 Fondaparinux Market: Product Market Share Analysis, 2024 & 2030
Fig. 21 Branded Market, 2018 - 2030 (USD Million)
Fig. 22 Generic Market, 2018 - 2030 (USD Million)
Fig. 23 Fondaparinux Market: Distribution Channel Segment Dashboard
Fig. 24 Fondaparinux Market: Distribution Channel Market Share Analysis, 2024 & 2030
Fig. 25 Hospital Pharmacies Market, 2018 - 2030 (USD Million)
Fig. 26 Retail Pharmacies Market, 2018 - 2030 (USD Million)
Fig. 27 Online Pharmacies Market, 2018 - 2030 (USD Million)
Fig. 28 Fondaparinux Market Revenue, By Region
Fig. 29 Regional Marketplace: Key Takeaways
Fig. 30 Regional Marketplace: Key Takeaways
Fig. 31 North America Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 32 U.S. Country Dynamics
Fig. 33 U.S. Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 34 Canada Country Dynamics
Fig. 35 Canada Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 36 Mexico Country Dynamics
Fig. 37 Mexico Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 38 Europe Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 39 UK Country Dynamics
Fig. 40 UK Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 41 Germany Country Dynamics
Fig. 42 Germany Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 43 France Country Dynamics
Fig. 44 France Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 45 Italy Country Dynamics
Fig. 46 Italy Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 47 Spain Country Dynamics
Fig. 48 Spain Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 49 Norway Country Dynamics
Fig. 50 Norway Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 51 Sweden Country Dynamics
Fig. 52 Sweden Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 53 Denmark Country Dynamics
Fig. 54 Denmark Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 55 Asia Pacific Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 56 Japan Country Dynamics
Fig. 57 Japan Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 58 China Country Dynamics
Fig. 59 China Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 60 India Country Dynamics
Fig. 61 India Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 62 Australia Country Dynamics
Fig. 63 Australia Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 64 South Korea Country Dynamics
Fig. 65 South Korea Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 66 Thailand Country Dynamics
Fig. 67 Thailand Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 68 Latin America Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 69 Brazil Country Dynamics
Fig. 70 Brazil Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 71 Argentina Country Dynamics
Fig. 72 Argentina Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 73 MEA Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 74 South Africa Country Dynamics
Fig. 75 South Africa Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 76 Saudi Arabia Country Dynamics
Fig. 77 Saudi Arabia Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 78 UAE Country Dynamics
Fig. 79 UAE Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 80 Kuwait Country Dynamics
Fig. 81 Kuwait Fondaparinux Market, 2018 - 2030 (USD Million)
Fig. 82 Company Categorization
Fig. 83 Company Market Position Analysis
Fig. 84 Strategic Framework

Companies Mentioned

  • Abbott Laboratories Inc.
  • Alchemia Limited
  • Apotex Inc.
  • GSK plc
  • Lupin Pharmaceuticals, Inc
  • ScinoPharm Taiwan Ltd
  • Dr. Reddy’s Laboratories Ltd.
  • Bayer Healthcare AG
  • GlaxoSmithKline
  • Boehringer Ingelheim
  • Sanofi
  • WisMed
  • Kaifeng
  • Mylan

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages100
PublishedMarch 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 688 Million
Forecasted Market Value ( USD ) by 2030 $ 990.9 Million
Compound Annual Growth Rate6.3%
Regions CoveredGlobal
No. of Companies Mentioned14

Related Topics

Related Reports

Fondaparinux Market by Product, Application - Global Forecast 2025-2030 - Product Image

Fondaparinux Market by Product, Application - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Fondaparinux - Global Strategic Business Report - Product Image

Fondaparinux - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Fondaparinux Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Fondaparinux Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 97 Pages
  • Global
From
Fondaparinux Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Image

Fondaparinux Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • 115 Pages
  • Global
From
Fondaparinux Market Analysis & Forecast to 2024-2034 - Product Image

Fondaparinux Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.